115 results
424B3
PASG
Passage Bio Inc
14 May 24
Prospectus supplement
8:15am
, a leader in the genetic medicines field. Our research collaboration with GTP provides us with access to one of the premier research institutions … to certain limitations. We also have access to platform technologies related to development of novel capsids, toxicity reduction technologies
S-3
PASG
Passage Bio Inc
4 Mar 24
Shelf registration
4:09pm
research collaboration with GTP provides us with access to one of the premier research institutions in the world for the discovery and preclinical … for certain rare monogenic and certain non-rare, non-monogenic, or large, CNS disorders, subject to certain limitations. We also have access to platform
8-K
EX-99.1
8asbdkeofgsj hc
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
8-K
EX-99.2
14sytc
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
8-K
EX-99.1
lhf5tab
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
8-K
EX-99.2
qrp7z0dxdfa2 iju61ew
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
8-K
EX-99.1
7tfg qnki
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
8-K
EX-99.2
euhrzxrr
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
PRE 14A
sd9vnt vm1
3 Apr 23
Preliminary proxy
4:05pm